Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Gold Set to Correct but Internals Remain Bullish

Last week we wrote that near-term risk in precious metals (Gold and GDX especially) was rising and a correction could begin soon. As Gold nearly reached major resistance at $1550/oz, the miners already began to correct. That negative divergence is an ominous signal for the...

Manchester United Investors Get a Kick from Silver Lake's Investment in Rival Football Club

Shares of Manchester United traded 12% higher today after private investment firm Silver Lake Partners announced that it is acquiring a $500 million stake in City Football Group, owner of the reigning English Premier League champions Manchester City. Today, shares of ...

Gold not in Real Bull Market Yet

Is Gold now back in a bull market? Most gold bugs think so and are quick to proclaim that. But, could Gold remain in a secular bear market? It hasn’t made a new all time high in 8 years and the perma-bull, financial asset loving crowd certainly believes so....

Fate Therapeutics Shares Rise 10% as First Person Treated with Its Anti-Cancer Therapy

Shares of Fate Therapeutics traded higher after the firm reported it has treated the first patient in a first-in-human trial of FT596 for patients with B-cell malignancies and chronic lymphocytic leukemia. Clinical-stage biopharmaceutical company Fate Thera...

Conversation with Katusa: The Biggest Short Squeeze in History

“We’re going to go through the biggest short squeeze in history, and it just so happens to be on the dollar.” Dear Reader, If you aren’t paying attention to the global squeeze of U.S. Dollars then you need to...

A Fresh Look at a New Military Tech Opportunity

(Click image to play video) It is a recognised fact that military spending – both globally and especially in the U.S. – is increasing and represents a highly lucrative market opportunity worth billions. Now, a well-positioned Canadian military and defense tech co...

The EV Battle is Heating Up: Enter “The Tesla Killer”

(IoniX Pro Home Smart Wall Product Rendering via Extreme Vehicle Battery Technologies Corp.) When it comes to the Electric Vehicle (EV) revolution, the future is imminent and those who have adopted this next level lifestyle agree that what they need is power … an...

Apple's (NASDAQ: AAPL) bet on Liquidmetal about to pay off?

Apple Inc. ( NASDAQ: AAPL , Stock Forum ) loves to think of lucrative new uses for other people's bright ideas. For instance, the original iPod wouldn't have been possible without Toshiba's innovative 1.8-inch hard drive. And when Steve Jobs learned about Gorilla Glass...

Silver’s Q4 Seasonal Outlook

What has been will be again, what has been done will be done again; there is nothing new under the sun. Ecclesiastes 1:9 History repeats itself. Not always, and not 100%, but often enough and to an extent that’s significant enough to make these repet...

Buzz on the Bullboards: Finding Diamonds in the Rough

While the markets were rocked at the end of January by the Wuhan coronavirus, the beginning of February has seen a return to the non-stop climb that began in last fall. Once we break things down by sector, however, the picture becomes murkier. The cannabis sector continues...
1 2 3